stock
CRBP · Corbus Pharmaceuticals Holdings, Inc.
What Corbus Pharmaceuticals Holdings, Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live CRBP price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on CRBP.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 19,341,293 as of 2026-08-04 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- —
- Net
- —
Returns
- ROE
- -99.7%
- ROA
- -80.2%
Health
- Current ratio
- 5.7x
- Debt/equity
- —
Deep value
- NCAV
- $98.00M
- NCAV per share
- $5.07
- Price/NCAV
- Locked
- NNWC
- -$1.38M
- NNWC per share
- -$0.07
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | — | —Gross profit: unreported by this company. | -$36.19M | -$35.04M | 10-Q filed 2026-08-06 |
| 2026-03-31 | — | —Gross profit: unreported by this company. | -$24.30M | -$22.97M | 10-Q filed 2026-05-12 |
| 2025-12-31 | — | —Gross profit: unreported by this company. | -$21.97M | -$20.55M | 10-K filed 2026-03-09 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2025-09-30 | — | —Gross profit: unreported by this company. | -$24.42M | -$23.34M | 10-Q filed 2025-11-12 |
| 2025-06-30 | — | —Gross profit: unreported by this company. | -$19.15M | -$17.66M | 10-Q filed 2026-08-06 |
| 2025-03-31 | — | —Gross profit: unreported by this company. | -$19.77M | -$16.98M | 10-Q filed 2026-05-12 |
| 2024-12-31 | — | —Gross profit: unreported by this company. | -$12.61M | -$9.53M | 10-K filed 2026-03-09 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2024-09-30 | — | —Gross profit: unreported by this company. | -$15.51M | -$13.78M | 10-Q filed 2025-11-12 |
- Assets
- $126.99M
- Equity
- $102.24M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | — | -$85.31M | -$78.54M | -$64.50M |
| 2024-12-31 | — | -$48.72M | -$40.21M | -$41.79M |
| 2023-12-31 | — | -$45.08M | -$44.60M | -$36.10M |
| 2022-12-31 | $0 | -$39.84M | -$42.35M | -$37.56M |
| 2021-12-31 | $881,705 | -$55.99M | -$45.64M | -$48.24M |
| 2020-12-31 | $3.94M | -$122.81M | -$111.27M | -$100.17M |
| 2019-12-31 | $36.14M | -$77.10M | -$71.45M | -$48.46M |
| 2018-12-31 | $4.82M | -$56.75M | -$55.67M | -$32.37M |
| 2017-12-31 | $2.44M | -$32.56M | -$32.42M | -$28.50M |
| 2016-12-31 | $1.91M | -$19.99M | -$20.00M | — |
Company filings
since Wed Mar 11 · 4 offering filings in 12 months · since Fri Aug 7
events
Regulation FD disclosure, Other event
Regulation FD disclosureOther eventSep 148-KResults, Regulation FD disclosure
ResultsRegulation FD disclosureAug 68-KMaterial agreement, Regulation FD disclosure
Material agreementRegulation FD disclosureJul 68-KRegulation FD disclosure, Other event
Regulation FD disclosureOther eventMay 268-KMaterial agreement, Executive or director change, Regulation FD disclosure
Material agreementExecutive or director changeRegulation FD disclosureMay 218-KExecutive or director change, Shareholder vote results, Regulation FD disclosure
Executive or director changeShareholder vote resultsRegulation FD disclosureMay 148-K
5% owners ()
RA Capital Management, L.P.
Passive stake
Citadel Advisors LLC
Stake update
BlackRock, Inc.
Passive stake
Octagon Capital Advisors LP
Stake update
Octagon Capital Advisors LP
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
Ben Yong
Director
Sale$15,683Sep 15, 4:59 PM ET
Saxena Nishant C
Chief Business Officer
Buy$25,036Aug 12, 4:30 PM ET
Cohen Yuval
Chief Executive Officer, Director
Sale$171,396Aug 10, 4:30 PM ET
Moran Sean F.
Chief Financial Officer
Sale$120,971Aug 10, 4:30 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
None of the tracked funds held this at their last 13F.
News
Stories that named CRBP, and the market events around them.
Sign in to see thisBoard
The CRBP board could not be loaded.
Retry the CRBP boardnakagai
Signals on CRBP come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the CRBP board